Vaso Corp (VASO): Gross Profit
$54.67M
Year ended 2025-12-31
+4.5%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $54.67M | +5.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $52.05M | +2.9% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $50.59M | +5.6% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $47.90M | n/c | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $43.13M | +11.8% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $38.57M | -9.1% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $42.43M | +3.2% | 2021-05-05, From 2019-01-01 |
| 2018-12-31 | $41.12M | +1.0% | 2020-04-14, From 2018-01-01 |
| 2017-12-31 | $40.73M | -1.9% | 2019-04-15, From 2017-01-01 |
| 2016-12-31 | $41.50M | +17.3% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $35.37M | +40.4% | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | $25.19M | +11.9% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $22.51M | +9.3% | 2015-03-30, From 2013-01-01 |
| 2012-12-31 | $20.59M | -6.0% | 2014-03-27, From 2012-01-01 |
| 2011-12-31 | $21.92M | n/a | 2013-04-01, From 2011-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Vaso Corp (VASO) | 2025-12-31 | $54.67M | +5.0% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $78.27M | +37.9% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $62.12M | +24.0% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $57.94M | +16.0% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $46.75M | +21.2% |
| Iridex Corp (IRIX) | 2026-01-03 | $19.23M | -1.4% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $167.35M | +17.9% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $17.07M | +17.0% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $27.79M | +29.9% |
Compare VASO, CBLL, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗